Full Name
Han Kiat Ho
Variants
Ho, H.K.
Ho H.K
Ho, Han Kiat
Ho Han Kiat
 
Main Affiliation
 
 
Email
phahohk@nus.edu.sg
 
 

Publications

Results 21-40 of 53 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
211-Jan-2021Extracellular Vesicle Proteome of Breast Cancer Patients with and Without Cognitive Impairment Following Anthracycline-based Chemotherapy: An Exploratory StudyKoh, YQ ; Ng, DQ ; Ng, CC ; Boey, A ; Wei, M ; Sze, SK ; Ho, HK ; Acharya, M; Limoli, CL; Chan, A 
215-Oct-2013Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human fecesPhua, L.C.; Koh, P.K.; Cheah, P.Y.; Ho, H.K. ; Chan, E.C.Y. 
32015Hepatotoxic potential of asarones: In vitro evaluation of hepatotoxicity and quantitative determination in herbal productsPatel, D.N ; Ho, H.K ; Tan, L.L; Tan, M.-M.B; Zhang, Q; Low, M.-Y; Chan, C.-L ; Koh, H.-L 
42020HPLC-MS/MS coupled with equilibrium dialysis method for quantification of free drug concentration of pazopanib in plasmaToh, Y.L.; Pang, Y.Y.; Shwe, Maung; Kanesvaran, R. ; Toh, C.K.; Chan, A.; Ho, H.K. 
52020Hypothermia Advocates Functional Mitochondria and Alleviates Oxidative Stress to Combat Acetaminophen-Induced HepatotoxicityTan, Y.L.; Ho, H.K. 
64-Jun-2012Immobilisation of quantum dots by bio-orthogonal PCR amplification and labelling for direct gene detection and quantitationTian, Q. ; Wong, W.; Xu, Y.; Chan, Y. ; Ho, H.K. ; Pastorin, G. ; Ang, W.H. 
72016Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer PatientsChae J.-W.; Ng T.; Yeo H.L.; Shwe M.; Gan Y.X.; HO HAN KIAT ; Chan A. 
82018Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson’s DiseaseBaek J.-S.; Tee J.K. ; Pang Y.Y. ; Tan E.Y.; Lim K.L. ; Ho H.K. ; Loo S.C.J.
920-Sep-2021In vivo demonstration of a novel non-invasive model for inducing localized hypothermia to ameliorate hepatotoxicityTan, Yeong Lan ; Nga, Min En ; Ho, Han Kiat 
10Jul-2012Interaction of lapatinib with cytochrome P450 3A5Chan, E.C.Y. ; New, L.S. ; Chua, T.B.; Yap, C.W. ; Ho, H.K. ; Nelson, S.D.
11Mar-2013Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapyPhua, L.C.; Mal, M.; Koh, P.K.; Cheah, P.Y.; Chan, E.C.Y. ; Ho, H.K. 
121-Sep-2017Investigation of the effect of plasma albumin levels on regorafenib-induced hepatotoxicity using a validated liquid chromatography-tandem mass spectrometry methodPang, YY ; Tan, YL ; Ho, HK 
131-Feb-2010Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicitySaha, S.; New, L.S. ; Ho, H.K. ; Chui, W.K. ; Chan, E.C.Y. 
1423-Mar-2012Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinomaPoh, W.; Wong, W.; Ong, H.; Aung, M.O.; Lim, S.G.; Chua, B.T.; Ho, H.K. 
152018Magnesium isoglycyrrhizinate ameliorates fibrosis and disrupts TGF-?-Mediated SMAD pathway in activated hepatic stellate cell line LX2Tee, J.K ; Peng, F ; Tan, Y.L; Yu, B; Ho, H.K 
161-Feb-2015Mechanism-based inactivation of CYP450 enzymes: A case study of lapatinibHo, Han Kiat ; Chan, James Chun Yip; Hardy, Klarissa D.; Chan, Eric Chun Yong 
172015Mechanism-based inactivation of CYP450 enzymes: A case study of lapatinibHo H.K ; Chan J.C.Y; Hardy K.D., Chan E.C.Y.
18Oct-2010Mechanism-based inactivation of cytochrome P450 3A4 by lapatinibTeng, W.C.; Oh, J.W.; New, L.S. ; Wahlin, M.D.; Nelson, S.D.; Ho, H.K. ; Chan, E.C.Y. 
192014Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury modelsTan C.Y. ; Lai R.C.; Wong W. ; Dan Y.Y. ; Lim S.-K. ; Ho H.K. 
202015Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendationsTeo Y.L ; Ho H.K ; Chan A